Skip to main content

Table 3 Diagnoses 6 months after index CT

From: Use and diagnostic outcomes of cancer patient pathways in Denmark – is the place of initial diagnostic work-up an important factor?

Diagnoses

CT scans referred by GP (n=228 522)

CT scans referred by hospital (n=284 640)

Crude OR (95%CI)

P-value crude

aAdjusted OR (95% CI)

P-value adjusted

All cancer and selected non-cancer diagnoses

80 525 (35.2)

100 637 (35.4)

1.00 (0.98 1.01)

0.377

1.01 (1.00 1.03)

0.046

All Cancers diagnoses

20 926 (9.2)

22 567 (7.9)

1.17 (1.15 1.19)

<.0001

1.12 (1.09 1.14)

<.0001

 Lung

5 031 (2.2)

3 831 (1.3)

1.65 (1.58 1.72)

<.0001

1.62 (1.55 1.69)

<.0001

 Breast

2 846 (1.3)

4 301 (1.5)

0.82 (0.78 0.86)

<.0001

0.77 (0.73 0.81)

<.0001

 Prostate

2 541 (1.1)

3 582 (1.3)

0.88 (0.84 0.93)

<.0001

0.85 (0.81 0.90)

<.0001

 Colon

3 203 (1.4)

3 364 (1.2)

1.19 (1.13 1.25)

<.0001

1.11 (1.05 1.16)

0.0001

 Melanoma of skin

778 (0.3)

943 (0.3)

1.03 (0.94 1.13)

0.573

1.02 (0.92 1.13)

0.7106

 Bladder

1 445 (0.6)

977 (0.3)

1.85 (1.71 2.01)

<.0001

1.80 (1.65 1.96)

<.0001

 Brain, central nervous system

477 (0.2)

421 (0.2)

1.42 (1.24 1.62)

<.0001

1.40 (1.22 1.60)

<.0001

 Rectum and anus

1 189 (0.5)

1 691 (0.6)

0.88 (0.81 0.94)

0.0005

0.80 (0.74 0.86)

<.0001

 Non-Hodgkin lymphoma

905 (0.4)

1 135 (0.4)

0.99 (0.91 1.08)

0.878

0.97 (0.88 1.06)

0.4406

 Pancreas

1 006 (0.4)

792 (0.3)

1.59 (1.44 1.74)

<.0001

1.50 (1.36 1.65)

<.0001

 Endometrium

492 (0.2)

567 (0.2)

1.08 (0.96 1.22)

0.2050

1.04 (0.92 1.18)

0.5476

 Kidney

1 192 (0.5)

1 072 (0.4)

1.39 (1.28 1.51)

<.0001

1.37 (1.26 1.49)

<.0001

 Ovary

498 (0.2)

508 (0.2)

1.22 (1.08 1.39)

0.0014

1.08 (0.95 1.23)

0.2154

 Stomach

392 (0.2)

441 (0.2)

1.11 (0.97 1.27)

0.1403

1.03 (0.90 1.19)

0.6748

Selected non-cancer diagnoses

66 463 (29.1)

85 865 (30.2)

0.95 (0.94 0.96)

<.0001

0.97 (0.96 0.99)

<.0001

 Coronary heart disease

7 519 (3.3)

15 978 (5.6)

0.572 (0.560.59)

<.0001

0.55 (0.54 0.57)

<.0001

 Heart failure

3 309 (1.5)

6 762 (2.4)

0.60 (0.58 0.63)

<.0001

0.64 (0.61 0.67)

<.0001

 Peripheral vascular disease

4 690 (2.1)

6 890 (2.4)

0.85 (0.81 0.88)

<.0001

0.84 (0.81 0.87)

<.0001

 Chronic obstructive pulmonary disease

8 666 (3.8)

14 515 (5.1)

0.73 (0.71 0.75)

<.0001

0.79 (0.77 0.81)

<.0001

 Diabetes

6 078 (2.7)

8 134 (2.9)

0.93 (0.90 0.96)

<.0001

0.96 (0.93 0.99)

0.022

 Liver disease

2 353 (1.0)

3 181 (1.1)

0.92 (0.87 0.97)

0.0026

1.00 (0.94 1.05)

0.872

 Thyroid disorders

3 317 (1.5)

4 073 (1.4)

1.02 (0.97 1.06)

0.539

1.03 (0.99 1.09)

0.1701

 Kidney disease

3 618 (1.6)

4 643 (1.6)

0.97 (0.93 1.01)

0.176

0.96 (0.92 1.01)

0.096

 Inflammatory bowel disease

2 325 (1.0)

2 817 (1.0)

1.03 (0.97 1.09)

0.321

1.06 (1.00 1.12)

0.042

 Ulcer

1 939 (0.9)

2 930 (1.0)

0.82 (0.78 0.87)

<.0001

0.86 (0.81 0.92)

<.0001

 Hemiplegia/stroke

19 427(8.5)

20 074 (7.1)

1.23 (1.20 1.25)

<.0001

1.30 (1.27 1.33)

<.0001

 Parkinson disease

584 (0.3)

726 (0.3)

1.00 (0.90 1.12)

0.9999

1.02 (0.91 1.14)

0.791

 Multiple sclerosis

236 (0.1)

233 (0.1)

1.26 (1.06 1.52)

0.011

1.43 (1.19 1.72)

0.0002

 Epilepsy

2 063 (0.9)

3 182 (1.1)

0.81 (0.76 0.85)

<.0001

0.86 (0.81 0.91)

<.0001

 Dementia

7 894 (3.5)

4 730 (1.7)

2.12 (2.04 2.20)

<.0001

2.23 (2.15 2.32)

<.0001

 Osteoporosis

4 568 (2.0)

7 332 (2.6)

0.77 (0.74 0.80)

<.0001

0.70 (0.68 0.73)

<.0001

 Rheumatoid and connective tissue disease

3 020 (1.3)

3 616 (1.3)

1.04 (0.99 1.09)

0.106

1.04 (0.99 1.09)

0.145

 HIV/AIDS

50 (0.02)

66 (0.02)

0.94 (0.65 1.36)

0.758

1.05 (0.72 1.54)

0.786

 Depression/ anxiety

4 940 (2.1)

6 381 (2.2)

0.96 (0.93 1.00)

0.053

1.06 (1.02 1.10)

0.0042

 Psychotic diseases

679 (0.3)

1 427 (0.5)

0.59 (0.54 0.65)

<.0001

0.70 (0.63 0.77)

<.0001

  1. aOR for cancer or selected non-cancer diagnoses in CT-GP vs. CT-HO, adjusted for age, sex, country of origin, Region of residence, education affiliation to work market, cohabitation status and non-cancer morbidity